| State | Name as filed |
|---|---|
| CA | Invitae Corporation |
| State | Agency | Source key | Raw status | Status | Stage | Review type |
|---|---|---|---|---|---|---|
| CA | Office of Health Care Affordability (HCAI) | mcn-invitae-05-2024 | CMIR Waived | WAIVED | NOTICE | The transaction is an asset sale, through which LabCorp Genetics, Inc., a newly formed entity, will acquire certain assets of Invitae Corporation in accordance with the negotiated Asset Purchase Agreement and certain requirements under the bankruptcy code. |
| Date | Date kind | Event | Raw text | Source |
|---|---|---|---|---|
| 2024-06-05 | PUBLISHED | NOTICE_ACCEPTED | Date Submission Completed: June 5, 2024 | CA agency page |
| not dated | PUBLISHED | CMIR_WAIVED | CMIR Waived | CA agency page |
| Source | Captured at (UTC) |
|---|---|
| https://hcai.ca.gov/affordability/ohca/assess-market-consolidation/material-change-transaction-notices-mcn-and-cost-and-market-impact-review-cmir/ | 2026-09-26T11:15:42.293Z |